Clinical Neuro-Oncology is a field of Medicine devoted to the management of diseases of the nervous system and their related structures which are caused by abnormal cell growth in brain and spinal cord. This field integrates treatment with prevention, diagnosis, rehabilitation, palliative care, epidemiology and research. The clinical management of Neuro-Oncologic disorders relies on a combination of medical, surgical and radiation treatments which are administered according to individual patient and tumour characteristics. Neuro-Oncology also encompasses the psycho-social care of an individual diagnosed with a tumour, and their family. Neuro-Oncologic diagnosis is based on a range of investigations, such as MRI and CT, that are used for diagnosis, staging and to measure treatment response. Surgery is used to remove gross tumour, alleviate pressure, diagnose and stage pathology and in some cases undertake neuro-navigation/stereo tactics biopsies. Medical care of Neuro-Oncologic diseases relies on even newer and advanced chemo and targeted therapy drugs. Radiation therapy is used as adjuvant therapy in certain Neuro-Oncologic scenarios. The science of Neuro-oncology has evolved impressively over the last few years with advances in technology, medical and surgical interventions, and the range of chemotherapy and targeted therapies now available. Rehabilitation is a critical component of Neuro-Oncology as physical, psychological and social deficits can result when neuro-oncologic conditions arise. Physical, occupational and speech therapies, psychological therapies and cognitive rehabilitation are some of the interventions that are tailored to individual patient needs. Finally, palliative care is essential for individuals and their families across all stages of a Neuro-Oncologic disorder.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States